Polymers have been widely used for the development of drug delivery systems accommodating the regulated release of therapeutic agents in consistent doses over a long period, cyclic dosing, and the adjustable release of both hydrophobic and hydrophilic drugs. Nowadays, polymer blends are increasingly employed in drug development as they generate more promising results when compared to those of homopolymers. This review article describes the recent research efforts focusing on the utilization of chitosan blends with other polymers in an attempt to enhance the properties of chitosan. Furthermore, the various applications of chitosan blends in drug delivery are thoroughly discussed herein. The literature from the past ten years was collected using various search engines such as ScienceDirect, J-Gate, Google Scholar, PubMed, and research data were compiled according to the various novel carrier systems. Nanocarriers made from chitosan and chitosan derivatives have a positive surface charge, which allows for control of the rate, duration, and location of drug release in the body, and can increase the safety and efficacy of the delivery system. Recently developed nanocarriers using chitosan blends have been shown to be cost-effective, more efficacious, and prolonged release carriers that can be incorporated into suitable dosage forms.

Background/Objectives: Wound management presents a substantial clinical challenge due to the rising incidence of chronic wounds, infections, and the limitations of conventional dressings in creating an ideal healing microenvironment. This review aims to provide a comprehensive overview of advanced smart hydrogel platforms designed to improve wound healing outcomes, focusing on their capacity to respond adaptively to physiological and external stimuli. Methods: This article analyzes the core characteristics of smart hydrogels, specifically examining stimuli-responsive systems (pH, temperature, enzyme, light, and electricity). The review evaluates advanced configurations—including injectable, self-healing, and 3D-printable systems—and functionalized hydrogels integrated with antimicrobials, drugs, and nanocomposites. Additionally, essential characterization methodologies, biological assessments, and regulatory considerations for clinical translation are synthesized. Results: The literature, which is predominantly preclinical in nature, indicates that functionalized hydrogels significantly enhance tissue regeneration, angiogenesis, and infection control compared to traditional methods. Conductive hydrogels utilizing bioelectrical signals show particular promise in accelerating the healing process. While current clinical applications and commercial products demonstrate efficacy, significant barriers remain regarding large-scale manufacturing and regulatory approval. Conclusions: Smart hydrogels represent a transformative approach to precision wound management, offering superior adaptability and therapeutic delivery. To achieve widespread clinical adoption, future research must address manufacturing scalability and focus on emerging trends, such as the integration of biosensors and AI-powered monitoring systems, to create fully intelligent wound care solutions.